General Information
edit

Offices
edit

Seattle, USA

Seattle, WA
USA

TOTAL	$2.1M
FUNDING TOTAL	$2.1M
Series A, 8/11 Accelerator Corp. OVP Venture Partners Alexandria Real Estate Equities Amgen Ventures ARCH Venture Partners WRF Capital	$2.1M

Oncofactor Corporation is a Seattle, WA-based developer of cancer therapeutics that disrupt signaling pathways between tumors and the immune system.

Oncofactor Corporation received $2.1M in Series A funding. (8/2/11)

Posted 5/24/11 at 3:33am via onbiovc.com

Edit This Page
Last Edited 3/29/13